A 16 week liraglutide administration in an adult with Wolfram syndrome transiently (4 weeks) improved glucose tolerance [21], while in another individual with an autosomal dominant WFS1 mutation insulin therapy could be discontinued with GLP-1 analogue treatment [49]. This evidence concerns the gene WFS1 and Wolfram syndrome.